SANOFI CHIMIE

Overview

SANOFI CHIMIE is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering ALFUZOSIN HYDROCHLORIDE; AVANAFIL; IRBESARTAN DRUG SUBSTANCE.

API / Drug Master Files

SANOFI CHIMIE holds 3 active (34 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• AVANAFILActive2014-10-07
• ALFUZOSIN HYDROCHLORIDEActive2007-09-27
• IRBESARTAN DRUG SUBSTANCEActive1993-06-30
• TRIMIPRAMINE MALEATEInactive2011-07-06
• SEMULOPARIN SODIUMInactive2011-06-06
• SAREDUTANT SUCCINATE DRUG SUBSTANCEInactive2007-10-02
• SATAVAPTAN PHOSPHATE MONOHYDRATE DRUG SUBSTANCEInactive2007-08-23
• HYDROXY ACIDInactive2004-04-08
• 17-DEACETYLNORGESTIMATE (NORELGESTROMIN)Inactive2004-01-23
• LEVOMEPROMAZINE MALEATEInactive2003-08-05
• LEVOMEPROMAZINE HYDROCHLORIDEInactive2003-07-10
• ZOPICLONEInactive2001-12-03
• PREDNISOLONE SODIUM METASULFOBENZOATEInactive2001-10-08
• FONDAPARINUX SODIUMInactive2001-01-22
• TRIMEGESTONEInactive1996-12-11

Showing 15 of 34 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SANOFI CHIMIE in our records. PharmaTek screens the full directory against live FDA enforcement data.